Gland Pharma has received tentative approval from the United States Food and Drug Administration (USFDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024%.
Posts in category Business Standard
ITC hits Rs 500: Jefferies says ‘Buy’ on no tobacco tax rejig in Budget (24-07-2024)
ITC share price target: ITC stock hits Rs 500-mark for the first time. Jefferies upgrades stock to ‘Buy’, Macquarie initiates with ‘Outperform’
Adani Green operationalizes 250 MW wind power project in Kutchh (24-07-2024)
Adani Green Energy said that its wholly-owned stepdown subsidiary Adani Renewable Energy Forty One has operationalized 250 MW of wind power project at Khavda, Kutchh, Gujarat.
Consumer Durables shares gain (24-07-2024)
Consumer Durables stocks were trading in the positive zone, with the BSE Consumer Durables index rising 793.59 points or 1.34% at 59829.77 at 09:42 IST.
Power shares gain (24-07-2024)
Power stocks were trading in the positive zone, with the BSE Power index rising 93.44 points or 1.19% at 7917.79 at 09:42 IST.
Utilties shares rise (24-07-2024)
Utilties stocks were trading with gains, with the BSE Utilities index rising 71.18 points or 1.15% at 6268.48 at 09:42 IST.
MIC Electronics develops GPS based PA, PIS and LED destination boards (24-07-2024)
Powered by Capital Market – Live News
Nestle Q1 Preview: Analysts eye strong revenue growth, margin expansion (24-07-2024)
Nestle India experienced robust revenue growth during the quarter. The company, analysts believe, gained from enhanced distribution. Thus, it is expected to see margin expansion of over 100 bps.
Asian stocks subdued after lacklustre earnings from US tech; yen firms (24-07-2024)
The US dollar was broadly firm, with traders watching out for an inflation reading on Friday and Federal Reserve meeting next week
Bajel Projects secures contract of Rs 586.28 cr from PowerGrid (24-07-2024)
Powered by Capital Market – Live News